Literature DB >> 8824646

Review article: the use of botulinum toxin in the alimentary tract.

A Albanese1, A R Bentivoglio, E Cassetta, A Viggiano, G Maria, D Gui.   

Abstract

New and future indications for the treatment of disorders of the alimentary tract using local injections of botulinum toxin are reviewed. Clinical experience shows that overactive smooth muscle sphincters may be weakened to treat disorders such as achalasia or chronic anal fissure. By contrast, injections placed into the sphincter of Oddi have proven less effective for postcholecystectomy pain syndrome. Experimental evidence suggests that food intake may be reduced by weakening the distal stomach with botulinum toxin. This approach may possibly lead to the treatment of obesity. There are some new possible indications for the use of botulinum toxin on the alimentary tract, and infantile hypertrophic pyloric stenosis seems to be the most promising new development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8824646     DOI: 10.1111/j.1365-2036.1995.tb00428.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

Review 1.  The Role of Endoscopic Intra-Gastric Botulinum Toxin-A for Obesity Treatment.

Authors:  Hadya Elshakh; Khalid El-Ejji; Shahrad Taheri
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

2.  Response to Letter to the Editor Re: "EUS-Guided Intragastric Injection of Botulinum Toxin A in the Preoperative Treatment of Super-Obese Patients: a Randomized Clinical Trial".

Authors:  Igor Braga Ribeiro; Diogo Turiani Hourneaux de Moura; Eduardo Guimarães Hourneaux de Moura
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

3.  EUS-Guided Intragastric Injection of Botulinum Toxin A in the Preoperative Treatment of Super-Obese Patients: a Randomized Clinical Trial.

Authors:  Eduardo Guimarães Hourneaux de Moura; Igor Braga Ribeiro; Mariana Souza Varela Frazão; Luiz Henrique Mazzonetto Mestieri; Diogo Turiani Hourneaux de Moura; Creusa Maria Roveri Dal Bó; Vitor Ottoboni Brunaldi; Eduardo Turiani Hourneaux de Moura; Gabriel Cairo Nunes; Fábio Alberto Castillo Bustamante; Manoel Dos Passos Galvão Neto; Sergio Eiji Matuguma; Wanderley Marques Bernardo; Marco Aurélio Santo
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

4.  Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

Authors:  R C Dodel; A Kirchner; R Koehne-Volland; G Künig; A Ceballos-Baumann; M Naumann; A Brashear; H P Richter; T D Szucs; W H Oertel
Journal:  Pharmacoeconomics       Date:  1997-12       Impact factor: 4.981

5.  Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A.

Authors:  Jorge E Zuniga; Jared T Hammill; Omri Drory; Jonathan E Nuss; James C Burnett; Rick Gussio; Peter Wipf; Sina Bavari; Axel T Brunger
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

6.  Late-onset hypertrophic pyloric stenosis with gastric outlet obstruction: case report and review of the literature.

Authors:  Lindsey L Wolf; Amar Nijagal; Alejandro Flores; Terry L Buchmiller
Journal:  Pediatr Surg Int       Date:  2016-08-09       Impact factor: 1.827

7.  Comparison of safety and efficacy of intragastric botulinum toxin-A versus gastric balloon.

Authors:  Raed M Tayyem; Haitham G Qandeel; Hamzeh I Al-Balas; Farah R Tayyem; Jehad Z Fataftah; Mahmoud I Al-Balas
Journal:  Saudi J Gastroenterol       Date:  2022 Jul-Aug       Impact factor: 3.214

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.